HomePANG • BME
add
Pangaea Oncology SA
Previous close
€1.79
Year range
€1.68 - €2.12
Market cap
61.60M EUR
Avg Volume
704.00
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.24M | 95.74% |
Operating expense | 3.65M | 106.93% |
Net income | -1.87M | -109.37% |
Net profit margin | -57.70 | -6.97% |
Earnings per share | — | — |
EBITDA | -849.92K | 8.37% |
Effective tax rate | -52.70% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.79M | -67.22% |
Total assets | 28.83M | 1.61% |
Total liabilities | 10.03M | 89.10% |
Total equity | 18.81M | — |
Shares outstanding | 30.14M | — |
Price to book | 3.03 | — |
Return on assets | -9.71% | — |
Return on capital | -12.62% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.87M | -109.37% |
Cash from operations | -738.68K | 41.05% |
Cash from investing | -712.63K | -96.79% |
Cash from financing | 378.87K | 137.40% |
Net change in cash | -1.07M | 59.22% |
Free cash flow | -270.16K | 19.04% |
About
Founded
2006
Website
Employees
149